Patents by Inventor Josef Wieser

Josef Wieser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190308238
    Abstract: A method and a device for regulating a continuous casting system. The continuous casting system has a mold (1) and a strand guide (8) which is arranged downstream of the mold (1). Molten metal (3) is cast into the mold (1), in particular via an inlet device (4). The molten metal hardens on walls (1a) of the mold (1), such that a metal strand (7) with a hardened strand shell (5) and a still liquid core (6) is formed. The metal strand (7) is drawn out of the mold (1) by mutually spaced rollers (8b) of the strand guide (8), and a measurement variable is ascertained which correlates to the undulation of the casting level formed in the mold. The measurement variable is processed using at least one computing specification and is used to reduce the undulation of the casting level. In order to reduce the undulations of the casting level, the mutual spacing of opposing rollers (8b) of the strand guide is changed cyclically prior to the full hardening point (D).
    Type: Application
    Filed: December 6, 2017
    Publication date: October 10, 2019
    Inventors: Paul Felix DOLLHÄUBL, Josef WATZINGER, Philipp WIESER
  • Patent number: 9534004
    Abstract: The present invention relates to novel crystalline forms of ceftaroline fosamil and to methods for their preparation. Furthermore the present invention relates to the use of the novel forms of ceftaroline fosamil for the preparation of an antibiotic medicament. In addition the present invention relates to pharmaceutical compositions comprising an effective amount of the novel forms of ceftaroline fosamil and to methods of preparing the same. Finally the present invention relates to pharmaceutical combinations comprising an effective amount of the novel forms of ceftaroline fosamil and ?-lactamase inhibitors.
    Type: Grant
    Filed: December 19, 2013
    Date of Patent: January 3, 2017
    Assignee: SANDOZ AG
    Inventors: Josef Wieser, Hubert Sturm, Arthur Pichler, Andreas Hotter, Nolwenn Martin, Christoph Langes, Ulrich Griesser
  • Patent number: 9481698
    Abstract: The present invention relates to a novel process for preparing ceftaroline fosamil as well as to intermediates of this process.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: November 1, 2016
    Assignee: Sandoz AG
    Inventors: Hubert Sturm, Josef Wieser
  • Patent number: 9458146
    Abstract: A crystalline sodium salt of a compound of formula I (INN: Raltegravir) or a hydrate/solvate thereof is disclosed as well as a process for obtaining the same.
    Type: Grant
    Filed: April 27, 2012
    Date of Patent: October 4, 2016
    Assignee: SANDOZ AG
    Inventors: Frtiz Blatter, Katharina Reichenbächer, Robert Ziegert, Josef Wieser, Johannes Ludescher
  • Patent number: 9440924
    Abstract: The present invention relates to a novel solvate of ivabradine hydrochloride, a process of its preparation and its use for the preparation of specific polymorphic forms of ivabradine hydrochloride.
    Type: Grant
    Filed: July 31, 2012
    Date of Patent: September 13, 2016
    Assignee: SANDOZ AG
    Inventors: Josef Wieser, Ulrich Griesser, Michael Enders, Volker Kahlenberg
  • Publication number: 20160200750
    Abstract: The present invention relates to novel crystalline forms of ceftaroline fosamil and to methods for their preparation. Furthermore the present invention relates to the use of the novel forms of ceftaroline fosamil for the preparation of an antibiotic medicament. In addition the present invention relates to pharmaceutical compositions comprising an effective amount of the novel forms of ceftaroline fosamil and to methods of preparing the same. Finally the present invention relates to pharmaceutical combinations comprising an effective amount of the novel forms of ceftaroline fosamil and ?-lactamase inhibitors.
    Type: Application
    Filed: December 19, 2013
    Publication date: July 14, 2016
    Inventors: Josef Wieser, Hubert Sturm, Arthur Pichler, Andreas Hotter, Nolwenn Martin, Christoph Langes, Ulrich Griesser
  • Publication number: 20160046655
    Abstract: The present invention relates to a novel process for preparing ceftaroline fosamil as well as to intermediates of this process.
    Type: Application
    Filed: September 27, 2013
    Publication date: February 18, 2016
    Inventors: Hubert Sturm, Josef Wieser
  • Patent number: 9260389
    Abstract: The present invention relates to novel polymorphic forms of Saxagliptin Hydrochloride. The present invention also relates to methods of making polymorphic forms of Saxagliptin Hydrochloride.
    Type: Grant
    Filed: October 2, 2013
    Date of Patent: February 16, 2016
    Assignee: SANDOZ AG
    Inventors: Arthur Pichler, Josef Wieser, Christoph Langes, Milica Vukicevic
  • Publication number: 20140336179
    Abstract: The present invention relates to a novel solvate of ivabradine hydrochloride, a process of its preparation and its use for the preparation of specific polymorphic forms of ivabradine hydrochloride.
    Type: Application
    Filed: July 31, 2012
    Publication date: November 13, 2014
    Applicant: SANDOZ AG
    Inventors: Josef Wieser, Ulrich Griesser, Michael Enders, Volker Kahlenberg
  • Publication number: 20140200252
    Abstract: The present invention relates to novel polymorphic forms of Saxagliptin Hydrochloride. The present invention also relates to methods of making polymorphic forms of Saxagliptin Hydrochloride.
    Type: Application
    Filed: October 2, 2013
    Publication date: July 17, 2014
    Applicant: SANDOZ AG
    Inventors: Arthur Pichler, Josef Wieser, Christoph Langes, Milica Vukicevic
  • Publication number: 20140135353
    Abstract: A crystalline sodium salt of a compound of formula I (INN: Raltegravir) or a hydrate/solvate thereof is disclosed as well as a process for obtaining the same.
    Type: Application
    Filed: April 27, 2012
    Publication date: May 15, 2014
    Applicant: SANDOZ AG
    Inventors: Fritz Blatter, Katharina Reichenbächer, Robert Ziegert, Josef Wieser, Johannes Ludescher
  • Patent number: 8563555
    Abstract: The present invention relates to a pharmaceutical composition comprising crystalline form Y of posaconazole. The pharmaceutical composition can be used to treat or prevent fungal infections.
    Type: Grant
    Filed: May 28, 2009
    Date of Patent: October 22, 2013
    Assignee: Sandoz AG
    Inventors: Josef Wieser, Arthur Pichler, Andreas Hotter, Ulrich Griesser, Christoph Langes, Christian Laschober
  • Patent number: 8513224
    Abstract: The present invention relates to crystalline form C of Tigecycline dihydrochloride and to methods for the preparation of the same. Furthermore the present invention relates to the use of crystalline form C of Tigecycline dihydrochloride as an intermediate for the preparation of an anti-infective medicament. Moreover the present invention relates to pharmaceutical compositions comprising crystalline form C of Tigecycline dihydrochloride in an effective amount and to the use of crystalline form C of Tigecycline dihydrochloride as an anti-infective medicament.
    Type: Grant
    Filed: December 18, 2009
    Date of Patent: August 20, 2013
    Assignee: Sandoz AG
    Inventors: Andreas Hotter, Josef Wieser, Arthur Pichler, Martin Decristoforo
  • Patent number: 8455639
    Abstract: The present invention is directed to a crystalline form of 2-[6-[3(R)-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-ylmethyl]-benzonitrile, a process for the preparation of said crystalline form and the use thereof in the manufacture of a pharmaceutical composition.
    Type: Grant
    Filed: December 18, 2009
    Date of Patent: June 4, 2013
    Assignee: Sandoz AG
    Inventors: Johannes Ludescher, Josef Wieser, Gerhard Laus
  • Patent number: 8435998
    Abstract: The present invention relates to crystalline form IV of posaconazole and pharmaceutical compositions comprising the same. The pharmaceutical composition can be used to treat or prevent fungal infections.
    Type: Grant
    Filed: June 25, 2009
    Date of Patent: May 7, 2013
    Assignee: Sandoz AG
    Inventors: Josef Wieser, Arthur Pichler, Andreas Hotter, Ulrich Griesser, Christoph Langes
  • Publication number: 20130012481
    Abstract: The present invention relates to crystalline forms A and B of Tigecycline hydrochloride and to methods for the preparation of the same. Furthermore the present invention relates to the use of crystalline forms A and B of Tigecycline hydrochloride as intermediates for the formulation of an anti-infective medicament. Moreover the present invention relates to pharmaceutical compositions comprising crystalline form A of Tigecycline hydrochloride in an effective amount and to the use of crystalline form A of Tigecycline hydrochloride as anti-infective medicament.
    Type: Application
    Filed: July 17, 2012
    Publication date: January 10, 2013
    Applicant: SANDOZ AG
    Inventors: Josef Wieser, Andreas Hotter, Arthur Pichler
  • Patent number: 8252946
    Abstract: The present invention relates to crystalline forms A and B of Tigecycline hydrochloride and to methods for the preparation of the same. Furthermore the present invention relates to the use of crystalline forms A and B of Tigecycline hydrochloride as intermediates for the formulation of an anti-infective medicament. Moreover the present invention relates to pharmaceutical compositions comprising crystalline form A of Tigecycline hydrochloride in an effective amount and to the use of crystalline form A of Tigecycline hydrochloride as anti-infective medicament.
    Type: Grant
    Filed: November 12, 2008
    Date of Patent: August 28, 2012
    Assignee: Sandoz AG
    Inventors: Josef Wieser, Andreas Hotter, Arthur Pichler
  • Publication number: 20120101277
    Abstract: The present invention relates to crystalline form II-S, its preparation and its use to prepare other crystalline forms of posaconazole, in particular crystalline form IV of posaconazole.
    Type: Application
    Filed: July 9, 2010
    Publication date: April 26, 2012
    Applicant: SANDOZ AG
    Inventors: Josef Wieser, Arthur Pichler, Andreas Hotter, Ulrich Griesser, Christoph Langes
  • Publication number: 20120088808
    Abstract: The present invention relates to novel polymorphic forms of Saxagliptin Hydrochloride. The present invention also relates to methods of making polymorphic forms of Saxagliptin Hydrochloride.
    Type: Application
    Filed: April 9, 2010
    Publication date: April 12, 2012
    Applicant: SANDOZ AG
    Inventors: Arthur Pichler, Josef Wieser, Christoph Langes, Milica Vukicevic
  • Patent number: RE47787
    Abstract: The present invention relates to a novel process for preparing ceftaroline fosamil as well as to intermediates of this process.
    Type: Grant
    Filed: August 8, 2018
    Date of Patent: December 31, 2019
    Assignee: Sandoz AG
    Inventors: Hubert Sturm, Josef Wieser